Otolaryngology · 2011 · 23 citations · 21 references
Health ProfessionsAudiologyOtolaryngologyHearing AssessmentHearing ScienceOtologyAuditory Brainstem Response TestingCochlear FunctionGlaucomaHearing ImpairmentHearing LossOtoacoustic EmissionsAuditory Nerve ThresholdsAuditory Pathway DisordersCochlear Function AssessmentCochlear Function TestingCochlear PhysiologyExfoliation SyndromePrimary Angle-closure GlaucomaRetrocochlear Pathology
OBJECTIVE: The aim of this prospective study was to audiologically evaluate consecutive glaucoma patients with or without exfoliation. STUDY DESIGN: Prospective study. SETTING: Glaucoma Unit and Audiology Department at a university hospital. SUBJECTS AND METHODS: Consecutive subjects with exfoliative glaucoma (XFG) or primary open-angle glaucoma (POAG) aged between 50 and 70 years were enrolled. Auditory thresholds at 0.5, 1.0, 2.0, 4.0, and 8.0 Hz were measured bilaterally. Cochlear activity was assessed by recording distortion product otoacoustic emissions (DPOEs). Functional changes in the retrocochlear auditory pathway were evaluated by auditory brainstem responses (ABRs). RESULTS: One hundred and ten patients with XFG and 85 patients with POAG who presented in a glaucoma clinic were investigated. The mean age of study patients was 66.2 ± 5.6 years; range, 50-70 years). The odds of pathologic ABR central transmission time (interpeak latencies I-III, III-V, and I-V and waves I, III, and V) were 4.34 times higher in patients with XFG than in patients with POAG (95% confidence interval [CI], 2.22-8.49; P < .001). This significant association remained after adjusting for sex and age (odds ratio [OR] 4.12; 95% CI, 2.07-8.22; P < .001). Furthermore, the odds of ABR remained significantly higher in patients with XFG than in patients with POAG (OR 4.36; 95% CI, 2.10-9.06; P < .001) after controlling for systemic diseases (arterial hypertension, coronary heart disease, high cholesterol, and stroke). CONCLUSION: In the first study to compare XFG and POAG monitoring of the peripheral and central auditory pathway, it has been documented that XFG patients show a greater prevalence of retrocochlear pathology.
21
Auditory Evoked Potentials: Basic Principles and Clinical Application
Anu Sharma · Ear and Hearing · 2008 · 288 citations
Clinical Applications of the Auditory Brainstem Response
Sridhar Krishnamurti · Ear and Hearing · 1999 · 134 citations
Evoked Potentials in Clinical Medicine
Thoru Yamada · Neurology · 1985 · 108 citations
Medicine, Neurology, Neuroscience +11